Review

Study on oral microflora related to pancreatic cancer

Expand

Received date: 2020-04-14

  Online published: 2022-07-28

Cite this article

LUO Danyang, GAO Yiming . Study on oral microflora related to pancreatic cancer[J]. Journal of Surgery Concepts & Practice, 2021 , 26(01) : 84 -86 . DOI: 10.16139/j.1007-9610.2021.01.018

References

[1] Gopinath D, Menon RK, Banerjee M, et al. Culture-independent studies on bacterial dysbiosis in oral and oropharyngeal squamous cell carcinoma: a systematic review[J]. Crit Rev Oncol Hematol, 2019, 139:31-40.
[2] Ozkan B, Topuk SN, Taser N, et al. Oral microbiota change, tooth decay and hemorrhoidal disease[J]. Anae-robe, 2015, 33:137.
[3] Corrêa JD, Calderaro DC, Ferreira GA, et al. Subgingival microbiota dysbiosis in systemic lupus erythematosus: association with periodontal status[J]. Microbiome, 2017, 5(1):34.
[4] Corrêa JD, Fernandes GR, Calderaro DC, et al. Oral microbial dysbiosis linked to worsened periodontal condition in rheumatoid arthritis patients[J]. Sci Rep, 2019, 9(1):8379.
[5] Herrera V, Parsonnet J. Helicobacter pylori and gastric adenocarcinoma[J]. Clin Microbiol Infect, 2009, 15(11):971-976.
[6] Wang C, Li J. Pathogenic microorganisms and pancreatic cancer[J]. Gastrointest Tumors, 2015, 2(1):41-47.
[7] Gullo L, Pezzilli R, Morselli-Labate AM, et al. Diabetes and the risk of pancreatic cancer[J]. N Engl J Med, 1994, 331(2):81-84.
[8] Huang BZ, Pandol SJ, Jeon CY, et al. New-onset diabetes, longitudinal trends in metabolic markers, and risk of pancreatic cancer in a heterogeneous population[J]. Clin Gastroenterol Hepatol, 2020, 18(8):1812-1821.e7.
[9] Michaud DS, Izard J. Microbiota, oral microbiome, and pancreatic cancer[J]. Cancer J, 2014, 20(3):203-206.
[10] Riviere GR, Riviere KH, Smith KS. Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer′s disease[J]. Oral Microbiol Immunol, 2002, 17(2):113-118.
[11] Hujoel PP, Drangsholt M, Spiekerman C, et al. An exploration of the periodontitis-cancer association[J]. Ann Epidemiol, 2003, 13(5):312-316.
[12] Ahn J, Segers S, Hayes RB. Periodontal disease, porphyromonas gingivalis serum antibody levels and orodigestive cancer mortality[J]. Carcinogenesis, 2012, 33(5):1055-1058.
[13] Michaud DS, Joshipura K, Giovannucci E, et al. A prospective study of periodontal disease and pancreatic cancer in US male health professionals[J]. J Natl Cancer Inst, 2007, 99(2):171-175.
[14] Olsen I, Taubman MA, Singhrao SK. Porphyromonas gingivalis suppresses adaptive immunity in periodontitis, atherosclerosis, and Alzheimer′s disease[J]. J Oral Microbiol, 2016, 8:33029.
[15] Fan X, Alekseyenko AV, Wu J, et al. Human oral microbiome and prospective risk for pancreatic cancer: a po-pulation-based nested case-control study[J]. Gut, 2018, 67(1):120-127.
[16] Wei MY, Shi S, Liang C, et al. The microbiota and microbiome in pancreatic cancer: more influential than expected[J]. Mol Cancer, 2019, 18(1):97.
[17] Michaud DS, Izard J, Wilhelm-Benartzi CS, et al. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study[J]. Gut, 2013, 62(12):1764-1770.
[18] Yu T, Guo F, Yu Y, et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy[J]. Cell, 2017, 170(3):548-563,e16.
[19] Ji Y, Liang X, Lu H. Analysis of by high-throughput sequencing: helicobacter pylori infection and salivary microbiome[J]. BMC Oral Health, 2020, 20(1):84.
[20] Xiao M, Wang Y, Gao Y. Association between Helicobacter pylori infection and pancreatic cancer development: a meta-analysis[J]. PLoS One, 2013, 8(9):e75559.
[21] Farrell JJ, Zhang L, Zhou H, et al. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer[J]. Gut, 2012, 61(4):582-588.
[22] Gaiser RA, Halimi A, Alkharaan H, et al. Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer[J]. Gut, 2019, 68(12):2186-2194.
Outlines

/